# Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

> **NCT04886388** · PHASE3 · COMPLETED · sponsor: **Better Therapeutics** · enrollment: 668 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** BT-001
- **OTHER:** Physician-guided Standard of Care for type 2 diabetes

## Key facts

- **NCT ID:** NCT04886388
- **Lead sponsor:** Better Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-22
- **Primary completion:** 2022-03-09
- **Final completion:** 2022-09-27
- **Target enrollment:** 668 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886388, "Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04886388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*